AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Mar 27, 2019
34491_dirs_2019-03-27_d7bd1b12-efd5-4261-a875-43513ab2bbd1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-03-27
Reporting Person: Sharp Shalini (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $13.20 | 2028-12-04 | Common Stock (147562) | Direct |
Footnotes
F1: The option vests as to 34% of the underlying shares on December 5, 2019 and vests in equal installments at the end of each successive three-month period over the following 24 months.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19